https://fdawatch.net/2026/10/19/the-rise-of-real-world-evidence-in-regulatory-strategy-part-3-rwe-in-accelerated-approvals/FDA Watch Podcasten2026-10-19T14:43:23+00:00The Rise of Real-World Evidence in Regulatory Strategy, Part 3: RWE in Accelerated ApprovalsFDA, regulation, FDA Watch, new episode, pharmaceuticals, AI, artificial intelligence, technology, drug development, drugs, business, pharma, accelerated approval, podcast series, RWE, real-world evidence, White & Case, Bethany Hills, Analysis Group, Maral DerSarkissian, Kodiak Strategic Consultants, Mark Robbins, expedited approval, FDORAhttps://fdawatch.net/wp-content/uploads/2025/08/fdawatch_artworkupdated8.5.jpg?w=150